Basil Intel is the only regulatory intelligence platform integrating both DailyMed and Drugs@FDA databases – delivering the complete picture for label strategy, precedent research, health authority negotiations, and competitive analysis. Explore and gain strategic insights from connected data across global labels, clinical trials, safety reports, and guidances.
Basil is the only labeling intelligence platform integrating both DailyMed and Drugs@FDA databases. Hourly updates across all global sources ensure you are working with the most current data.
Access the FDA's definitive source of truth for approved labels. Eliminate gaps and blind spots that plague platforms relying on DailyMed alone.
Ground every regulatory decision in complete, authoritative data – your regulatory insurance policy.
Side-by-side HTML comparisons across products, markets, and versions. AI-generated summaries automatically highlight similarities, differences, and significant changes. Upload proprietary labels for comparison against competitive sets.
20-second comparisons replace hours of manual analysis. AI distinguishes cosmetic changes from substantive safety updates. Zero comparison limits.
Accelerate labeling harmonization and competitive analysis. Make informed decisions faster.
Validated AI searches 30+ years of label history to identify winning precedent language for health authority negotiations. Cross-reference clinical trials mentioned in labels for complete regulatory context.
10x faster precedent identification. AI surfaces approved language patterns across therapeutic classes and regulatory jurisdictions.
Strengthen FDA/EMA negotiations with validated precedent. Reduce back-and-forth cycles with authoritative supporting evidence.
Cross-market comparison identifying alignment gaps and optimization opportunities. Superior Japanese translation quality. Automated harmonization analysis with actionable recommendations.
99% translation accuracy outperforming industry alternatives. Executive-ready reports showing global label alignment status.
Achieve optimal global alignment while maintaining local compliance. Master the balance of consistency and country-specific requirements.
Rapid regulatory answers from experienced specialists. Custom analyses and labeling solutions developed on demand. Expert guidance on precedent identification and best-in-class wording.
24-hour response guarantee versus 3-month windows from competitors. Access human expertise when AI alone isn't enough.
Never miss critical deadlines. Get expert answers when your team needs them most.
A rare disease program was stuck in extended labeling discussions with FDA over pediatric dosing language. Each review cycle took 3-4 weeks, and the team had already gone through two rounds without resolution. Basil's precedent search surfaced 23 approved labels with similar weight-based pediatric dosing in the same therapeutic area – including FDA labeling review comments explaining the agency's preferred language structure. The team submitted a precedent-backed proposal that FDA accepted in a single cycle. The result: labeling finalized 8 weeks faster, PDUFA date met, and launch preparations stayed on track.
"Before Basil, building a precedent package meant downloading dozens of approval packages and reading through thousands of pages. Now I can show my team exactly what FDA accepted before and why in under an hour."
Senior Director, Regulatory Affairs
Mid-Size Biopharma
